Brief: TScan Therapeutics Announces Publication In Cell Highlighting Discovery Of Tumor Antigens, TCRs For Treatment Of Solid Tumors Using Foundational Screening Technology
11/07/2022 12:14
July 11 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS ANNOUNCES PUBLICATION IN CELL
HIGHLIGHTING
THE DISCOVERY OF TUMOR ANTIGENS AND TCRS FOR THE TREATMENT OF
SOLID TUMORS USING FOUNDATIONAL SCREENING TECHNOLOGY
Source text for Eikon: ID:nGNX9hzgx9
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing